Stock listing
Xetra:AFW Align Technology, Inc. Aktie
German listing (Xetra) of Align Technology, Inc. · home listing NASDAQ:ALGN
Follow Align Technology, Inc. into a list and get an email when it puts out news.
Share price · XETR:AFW
€143.80 EUR -3.80 (-2.6%)
Close on Nov 20, 2026
- Day range
- €143.80 – €145.35 EURNov 20, 2026
- Market cap
- €10.22B EURAt the close on Nov 20, 2026 · price × 71.04M shares outstanding
- 52-week range
- €120.75 – €166.15 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €2,604 EURMedian day 6 shares · 15 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ALGN · Home | $155.17 USD | -8.79 (-5.4%) | 1,307,670 | $159.71 | $162.18 | $154.52 | $163.96 | Close on Nov 20, 2026 |
| Frankfurt:AFW | €141.30 EUR | -9.50 (-6.3%) | 201 | €142.20 | €142.20 | €141.30 | €150.80 | Close on Nov 20, 2026 |
| B3:A1LG34 | 234.97 BRL | 0.00 (0.0%) | — | 234.97 | 234.97 | 234.97 | 234.97 | Close on Nov 19, 2026 |
| LSE:0HCK | $156.71 USD | -4.06 (-2.5%) | 118 | $160.78 | $162.32 | $156.71 | $160.77 | Close on Nov 20, 2026 |
| Dusseldorf:AFW | €142.30 EUR | -3.65 (-2.5%) | — | €142.95 | €144.10 | €142.30 | €145.95 | Close on Nov 20, 2026 |
| Xetra:AFW | €143.80 EUR | -3.80 (-2.6%) | — | €145.35 | €145.35 | €143.80 | €147.60 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · XETR:AFW · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €146.05 | +3.35 | +2.3% | €142.45 | €146.05 | €142.45 | 23 | |
| €142.70 | -2.65 | -1.8% | €146.40 | €148.30 | €142.70 | 18 | |
| €145.35 | +8.00 | +5.8% | €134.35 | €145.35 | €134.35 | 0 | |
| €137.35 | +3.10 | +2.3% | €137.25 | €137.35 | €137.25 | 0 | |
| €134.25 | +0.20 | +0.1% | €134.15 | €134.25 | €134.15 | 0 | |
| €134.05 | -5.00 | -3.6% | €137.35 | €137.35 | €134.05 | 5 | |
| €139.05 | +0.65 | +0.5% | €137.30 | €139.65 | €137.30 | 43 | |
| €138.40 | +3.95 | +2.9% | €135.55 | €138.40 | €135.55 | 152 | |
| €134.45 | -3.35 | -2.4% | €136.80 | €136.95 | €134.45 | 103 | |
| €137.80 | +0.60 | +0.4% | €138.00 | €138.00 | €137.80 | 0 | |
| €137.20 | +3.20 | +2.4% | €138.40 | €138.40 | €137.20 | 0 | |
| €134.00 | -1.70 | -1.3% | €133.85 | €134.00 | €133.85 | 0 | |
| €135.70 | +3.20 | +2.4% | €134.20 | €135.70 | €134.20 | 28 | |
| €132.50 | +1.80 | +1.4% | €132.95 | €132.95 | €132.50 | 0 | |
| €130.70 | -1.85 | -1.4% | €132.20 | €132.20 | €130.70 | 0 | |
| €132.55 | +4.80 | +3.8% | €133.00 | €135.60 | €132.55 | 24 | |
| €127.75 | -0.55 | -0.4% | €128.30 | €128.30 | €127.75 | 0 | |
| €128.30 | +1.55 | +1.2% | €128.30 | €128.30 | €128.25 | 1 | |
| €126.75 | -0.75 | -0.6% | €125.80 | €126.75 | €125.80 | 7 | |
| €127.50 | +1.70 | +1.4% | €126.75 | €127.50 | €126.75 | 0 | |
| €125.80 | +0.85 | +0.7% | €125.80 | €125.80 | €125.75 | 6 | |
| €124.95 | -0.10 | -0.1% | €125.20 | €125.20 | €124.65 | 10 | |
| €125.05 | 0.00 | 0.0% | €125.65 | €126.30 | €125.05 | 6 | |
| €125.05 | -1.25 | -1.0% | €125.65 | €125.65 | €125.05 | 0 | |
| €126.30 | -4.10 | -3.1% | €128.45 | €128.45 | €124.60 | 1 | |
| €130.40 | +2.50 | +2.0% | €129.50 | €130.40 | €129.50 | 10 | |
| €127.90 | +1.10 | +0.9% | €127.60 | €128.80 | €127.60 | 2 | |
| €126.80 | -0.75 | -0.6% | €127.25 | €127.25 | €126.80 | 9 | |
| €127.55 | -0.35 | -0.3% | €127.70 | €127.90 | €127.55 | 14 | |
| €127.90 | -0.80 | -0.6% | €128.85 | €128.85 | €127.90 | 18 | |
| €128.70 | -0.20 | -0.2% | €128.20 | €129.25 | €128.20 | 31 | |
| €128.90 | -5.55 | -4.1% | €129.65 | €130.30 | €128.90 | 39 | |
| €134.45 | +2.75 | +2.1% | €134.40 | €134.45 | €133.95 | 112 | |
| €131.70 | +2.90 | +2.3% | €128.55 | €131.70 | €128.55 | 66 | |
| €128.80 | +1.05 | +0.8% | €129.60 | €129.60 | €128.80 | 24 | |
| €127.75 | -4.40 | -3.3% | €130.95 | €130.95 | €127.75 | 20 | |
| €132.15 | +6.35 | +5.0% | €132.25 | €132.25 | €132.15 | 0 | |
| €125.80 | -5.60 | -4.3% | €127.60 | €128.50 | €125.80 | 6 | |
| €131.40 | -0.55 | -0.4% | €132.00 | €132.00 | €131.40 | 0 | |
| €131.95 | +1.60 | +1.2% | €130.50 | €131.95 | €130.50 | 7 | |
| €130.35 | +1.30 | +1.0% | €130.05 | €130.35 | €130.05 | 0 | |
| €129.05 | -2.40 | -1.8% | €131.60 | €133.80 | €129.05 | 3 | |
| €131.45 | -5.75 | -4.2% | €130.85 | €131.45 | €130.85 | 13 | |
| €137.20 | +0.90 | +0.7% | €135.95 | €137.20 | €135.70 | 26 | |
| €136.30 | +0.45 | +0.3% | €137.05 | €137.05 | €136.30 | 0 | |
| €135.85 | +2.35 | +1.8% | €135.85 | €135.85 | €135.85 | 4 | |
| €133.50 | -9.50 | -6.6% | €133.50 | €133.50 | €133.50 | 4 | |
| €143.00 | -10.60 | -6.9% | €143.00 | €143.00 | €143.00 | 91 |
- Ticker
- Xetra:AFW
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Xetra
- Currency
- EUR
What changed lately
Latest news release · Nov 18, 2026
Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors
Latest earnings call · Oct 28, 2026
Align Technology (NASDAQ:ALGN) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Jul 29, 2026
Q2 2026 Earnings Presentation
Earnings · 36 slides
Latest news
Align Technology Announces $270 Million Accelerated Stock Repurchase Agreement
Nov 6, 2026
Closed €146.05 (+2.3%) on Nov 6, 2026
Align Technology Opens 2027 Annual Research Program to Advance Orthodontic and Dental Patient Care
Nov 2, 2026
Closed €137.35 (+2.3%) on Nov 3, 2026
9 quarter Financial Model ending Q3 2026
Oct 28, 2026
Closed €139.05 (+0.5%) on Oct 29, 2026
ALGN Q3 2026 Financial Slides and Historical Data
Oct 28, 2026
Closed €139.05 (+0.5%) on Oct 29, 2026
Align Technology Announces Third Quarter 2026 Financial Results
Oct 28, 2026
Closed €139.05 (+0.5%) on Oct 29, 2026
Align Technology Announces CEO Succession Plan
Oct 28, 2026
Closed €139.05 (+0.5%) on Oct 29, 2026
Align Technology, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 45 in the last 12 months · 229 in all · newest Nov 18, 2026 · oldest 2019
- Calls
- 27 calls with a replay · 27 with a transcript · latest Oct 28, 2026
- Decks
- 16 decks · latest Jul 29, 2026
Where Align Technology, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ALGN · Home listing | NASDAQ | United States | USD |
| gettex:AFW | gettex | Germany | EUR |
| LS Exchange:590375 | LS Exchange | Germany | EUR |
| Tradegate:AFW | Tradegate | Germany | EUR |
| BMV:ALGN | BMV | Mexico | MXN |
| Lang & Schwarz:590375 | Lang & Schwarz | Germany | EUR |
| Frankfurt:AFW | Frankfurt | Germany | EUR |
| B3:A1LG34 | B3 | Brazil | BRL |
| Milan:1ALGN | Milan | Italy | EUR |
| BOATS:ALGN | BOATS | United States | USD |
| LSE:0HCK | LSE | United Kingdom | USD |
| VIE:ALGN | Vienna | Austria | EUR |
| Dusseldorf:AFW | Dusseldorf | Germany | EUR |
| Hamburg:AFW | Hamburg | Germany | EUR |
| Hanover:AFW | Hanover | Germany | EUR |
| Munich:AFW | Munich | Germany | EUR |
| Stuttgart:AFW | Stuttgart | Germany | EUR |
| Turquoise:ALGNN | Turquoise | United Kingdom | USD |
| BIVA:ALGN | BIVA | Mexico | MXN |
| BX Swiss:AFW | BX Swiss | Switzerland | CHF |
| Xetra:AFW · This page | Xetra | Germany | EUR |
Valuation
P/E 22.4× against a median of 33.4×: 5th lowest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $9.88B USD
- P/E
- 22.4×
- EV/sales
- 2.4×
- EV/EBITDA
- 11.5×
- Price/book
- 2.6×
- Gross margin
- 69.1%
- Operating margin
- 14.9%
- Net margin
- 11.8%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 1.26
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Align Technology, Inc. · NASDAQ:ALGN | US$11.02B | US$9.88B | 22.4× | 2.4× | 11.5× | 2.6× | 11.8% | 0.0× | 1.26 |
| Coloplast A/S Class B · OMXCOP:COLO_B | US$15.08B | US$18.16B | 33.4× | 4.3× | 10.5× | 7.2× | 10.6% | 1.5× | n/a |
| Shanghai United Imaging Healthcare Co., Ltd. Class A · SSE:688271 | US$14.48B | US$13.77B | 54.1× | 5.9× | n/a | 4.4× | 11.5% | 0.1× | n/a |
| Solventum Corporation · NYSE:SOLV | US$14.36B | US$18.98B | 92.1× | 2.3× | 20.0× | 3.0× | 1.9% | 1.1× | 0.56 |
| Baxter International Inc. · NYSE:BAX | US$13.14B | US$12.00B | n/a | 1.0× | 16.2× | 2.0× | −6.2% | 0.1× | 0.97 |
| Penumbra, Inc. · NYSE:PEN | US$12.58B | US$11.90B | 80.1× | 7.6× | n/a | 7.9× | 10.1% | 0.0× | 0.18 |
| Smith & Nephew plc · LSE:SN. | US$12.54B | US$15.58B | 20.1× | 2.5× | 11.4× | 2.4× | 10.1% | 0.7× | n/a |
| The Cooper Companies, Inc. · NASDAQ:COO | US$11.20B | US$13.59B | 19.6× | 3.2× | 14.6× | 1.3× | 13.5% | 0.3× | 0.50 |
| Demant A/S · OMXCOP:DEMANT | US$10.68B | US$13.44B | 47.1× | 4.0× | 17.1× | 6.5× | 6.7% | 1.8× | n/a |
| Insulet Corporation · NASDAQ:PODD | US$9.24B | US$9.62B | 21.5× | 3.0× | 13.9× | 5.8× | 13.5% | 0.6× | 0.53 |
| Globus Medical, Inc. · NYSE:GMED | US$7.48B | US$7.07B | 13.4× | 2.3× | 7.4× | 1.6× | 17.8% | 0.0× | 0.89 |
| Median of the others | US$12.56B | US$13.51B | 33.4× | 3.1× | 14.2× | 3.7× | 10.4% | 0.5× | 0.55 |
Forecasts
5 strong buy · 2 buy · 8 hold · 1 sell · Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.
- Price target
- 185.79 USD · Analysts' mean
- EPS, year to Dec 2026
- 11.13 · 16 analysts
- Revenue, year to Dec 2026
- 4.13B · 15 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Jennifer L. Davis | Company’s next President and Chief Executive Officer (from Dec 31, 2026) |
| Julie Colletti | SVP Chief Legal and Regulatory Officer |
| Roger E. George | Senior Vice President, Chief Legal and Regulatory Officer |
| Frank Quinn | Vice President and General Manager, United States |
| Markus Sebastian | SVP of the EMEA Region |
| Raj Pudipeddi | Senior Vice President and CMO |
| Simon Beard | SVP of the Americas Region |
Board
| Director | Role |
|---|---|
| Anne Myong | Board of Directors |
| Quentin Blackford | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Align Technology (NASDAQ:ALGN) Q3 2026 Earnings Call | Wed, Oct 28, 2026 · 4:30 PM ET | Replay |
| Align Technology (NASDAQ:ALGN) Q2 2026 Earnings Call | Wed, Jul 29, 2026 · 4:30 PM ET | Replay |
| Align Technology (NASDAQ:ALGN) Q1 2026 Earnings Call | Wed, Apr 29, 2026 · 4:30 PM ET | Replay |
| Align Technology (NASDAQ:ALGN) Q4 2025 Earnings Call | Wed, Feb 04, 2026 · 4:30 PM ET | Replay |
| Align Technology (NASDAQ:ALGN) Q3 2025 Earnings Call | Wed, Oct 29, 2025 · 4:30 PM ET | Replay |
| Align Technology (NASDAQ:ALGN) Q2 2025 Earnings Call | Wed, Jul 30, 2025 · 4:30 PM ET | Replay |
| Align Technology (NASDAQ:ALGN) Q1 2025 Earnings Call | Wed, Apr 30, 2025 · 4:30 PM ET | Replay |
| Align Technology (NASDAQ:ALGN) Q4 2024 Earnings Call | Wed, Feb 05, 2025 · 4:30 PM ET | Replay |
| Align Technology (NASDAQ:ALGN) Q3 2024 Earnings Call | Wed, Oct 23, 2024 · 4:30 PM ET | Replay |
| Align Technology (NASDAQ:ALGN) Q2 2024 Earnings Call | Wed, Jul 24, 2024 · 4:30 PM ET | Replay |
All 27 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 28, 2026 · After close | +0.1% |
| Q2 2026 | Jul 29, 2026 · After close | −3.7% |
| Q1 2026 | Apr 29, 2026 · After close | −1.3% |
| Q4 2025 | Feb 4, 2026 · After close | +8.9% |
| Q3 2025 | Oct 29, 2025 · After close | +4.9% |
| Q2 2025 | Jul 30, 2025 · After close | −36.6% |
| Q1 2025 | Apr 30, 2025 · Before open | −2.5% |
| Q4 2024 | Feb 5, 2025 · After close | +0.9% |
| Q3 2024 | Oct 23, 2024 · After close | +4.2% |
| Q2 2024 | Jul 24, 2024 · After close | −7.7% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Apr 24, 2024 · After close | −1.1% |
| Q4 2023 | Jan 31, 2024 · After close | +2.3% |
| Q3 2023 | Oct 25, 2023 · After close | −24.9% |
| Q2 2023 | Jul 26, 2023 · After close | +13.4% |
| Q1 2023 | Apr 26, 2023 · After close | −10.4% |
| Q4 2022 | Feb 1, 2023 · After close | +27.4% |
| Q3 2022 | Oct 26, 2022 · After close | −18.1% |
| Q2 2022 | Jul 27, 2022 · After close | +7.5% |
| Q1 2022 | Apr 27, 2022 · After close | −15.5% |
| Q4 2021 | Feb 2, 2022 · After close | −0.5% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2026 Earnings Presentation | Earnings | 36 slides | Jul 29, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 38 slides | Apr 29, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 51 slides | Feb 4, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 45 slides | Oct 29, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 43 slides | Jul 30, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 43 slides | Apr 30, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 50 slides | Feb 5, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 46 slides | Oct 23, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 44 slides | Jul 24, 2024 |
| Q1 2024 Earnings Presentation | Earnings | 45 slides | Apr 24, 2024 |
All 16 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q4 2023 Earnings Presentation | Earnings | 54 slides | Jan 31, 2024 |
| Q3 2023 Earnings Presentation | Earnings | 43 slides | Oct 25, 2023 |
| Q2 2023 Earnings Presentation | Earnings | 43 slides | Jul 26, 2023 |
| Q1 2023 Earnings Presentation | Earnings | 45 slides | Apr 26, 2023 |
| Q3 2021 Earnings Presentation | Earnings | 31 slides | October 2021 |
| Q3 2012 Earnings Presentation | Earnings | 38 slides | Oct 22, 2012 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.03B | 4.00B | 3.86B | 3.73B | 3.95B | 2.47B | 2.41B | 1.97B | 1.47B | 1.08B |
| Cost of revenue | 1.32B | 1.20B | 1.16B | 1.10B | 1.02B | 708.7M | 662.9M | 518.6M | 356.5M | 264.6M |
| Gross profit | 2.71B | 2.80B | 2.71B | 2.63B | 2.94B | 1.76B | 1.74B | 1.45B | 1.12B | 815.3M |
| Research and development | 369.9M | 364.2M | 346.8M | 305.3M | 250.3M | 175.3M | 157.4M | 128.9M | 97.6M | 75.7M |
| Selling, general and administrative | 1.76B | 1.76B | 1.70B | 1.67B | 1.71B | 1.20B | 1.07B | 852.4M | ||
| Operating income | 545.8M | 607.6M | 643.3M | 642.6M | 976.4M | 387.2M | 542.5M | 466.6M | 353.6M | 248.9M |
| Depreciation and amortization | 237.4M | 145.0M | 142.4M | 125.8M | 108.7M | 93.5M | 79.0M | 54.7M | 37.7M | 24.0M |
| EBITDA | 783.2M | 752.7M | 785.7M | 768.4M | 1.09B | 480.7M | 621.5M | 521.3M | 391.4M | 272.9M |
| Income before tax | 585.3M | 609.0M | 641.2M | 599.1M | 1.01B | 378.9M | 562.7M | 466.7M | 364.8M | 242.6M |
| Income tax | 174.9M | 187.6M | 196.2M | 237.5M | 240.4M | -1.40B | 112.3M | 57.7M | 130.2M | 51.2M |
| Net income | 410.4M | 421.4M | 445.1M | 361.6M | 772.0M | 1.78B | 442.8M | 400.2M | 231.4M | 189.7M |
| Earnings per share, basic | 5.66 | 5.63 | 5.82 | 4.62 | 9.78 | 22.55 | 5.57 | 5.00 | 2.89 | 2.38 |
| Earnings per share, diluted | 5.65 | 5.62 | 5.81 | 4.61 | 9.69 | 22.41 | 5.53 | 4.92 | 2.83 | 2.33 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.09B | 1.04B | 937.4M | 942.0M | 1.10B | 960.8M | 550.4M | 636.9M | 449.5M | 389.3M |
| Short-term investments | 0 | 35.3M | 57.5M | 72.0M | 0 | 318.2M | 98.5M | 272.0M | 251.0M | |
| Receivables | 1.10B | 995.7M | 903.4M | 859.7M | 897.2M | 657.7M | 550.3M | 439.0M | 324.2M | 247.4M |
| Inventory | 226.3M | 254.3M | 296.9M | 338.8M | 230.2M | 139.2M | 112.1M | 55.6M | 31.7M | 27.1M |
| Current assets | 2.62B | 2.49B | 2.45B | 2.42B | 2.49B | 1.85B | 1.63B | 1.30B | 1.16B | 953.0M |
| Property, plant and equipment | 1.13B | 1.27B | 1.29B | 1.23B | 1.08B | 734.7M | 631.7M | 521.3M | 348.8M | 175.2M |
| Goodwill | 491.8M | 442.6M | 419.5M | 407.6M | 418.5M | 444.8M | 63.9M | 64.0M | 64.6M | 61.0M |
| Total assets | 6.23B | 6.21B | 6.08B | 5.95B | 5.94B | 4.83B | 2.50B | 2.05B | 1.78B | 1.40B |
| Accounts payable | 121.5M | 108.7M | 113.1M | 127.9M | 163.9M | 142.1M | 87.3M | 64.3M | 36.8M | 28.6M |
| Current liabilities | 1.92B | 2.04B | 2.07B | 1.93B | 1.92B | 1.33B | 971.0M | 692.1M | 500.1M | 354.3M |
| Total liabilities | 2.18B | 2.36B | 2.45B | 2.35B | 2.32B | 1.60B | 1.15B | 799.6M | 629.7M | 400.8M |
| Shareholders' equity | 4.05B | 3.85B | 3.63B | 3.60B | 3.62B | 3.23B | 1.35B | 1.25B | 1.15B | 999.3M |
| Shares outstanding | 71.4M | 73.8M | 75.1M | 77.3M | 78.7M | 78.9M | 78.4M | 79.8M | 80.0M | 79.6M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 593.2M | 738.2M | 785.8M | 568.7M | 1.17B | 662.2M | 747.3M | 554.7M | 438.5M | 247.7M |
| Capital spending | -102.4M | -115.6M | -177.7M | -291.9M | -401.1M | -154.9M | -149.7M | -223.3M | -195.7M | -70.6M |
| Free cash flow | 490.8M | 622.7M | 608.1M | 276.8M | 771.4M | 507.3M | 597.6M | 331.4M | 242.8M | 177.1M |
| Cash from investing | -112.4M | -254.9M | -195.9M | -213.3M | -563.4M | -231.5M | -350.4M | 6.93M | -251.5M | 73.0M |
| Cash from financing | -464.6M | -355.7M | -598.3M | -501.7M | -458.3M | -30.8M | -485.5M | -369.4M | -135.5M | -95.5M |
| Share buybacks | -465.9M | -352.9M | -592.4M | -435.0M | -375.0M | 0 | -400.0M | -300.0M | -103.8M | -96.2M |
| Change in cash | 51.2M | 106.4M | -3.84M | -157.8M | 138.7M | 410.3M | -86.4M | 187.4M | 57.1M | 221.8M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 19, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 19, 2026 | Insider trade | SEC |
| 8-K · Current report | Nov 18, 2026 | Management or board change | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 13, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 10, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Nov 5, 2026 | Material contract | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 5, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 4, 2026 | Quarterly report | SEC |
| 3 · Initial statement of ownership | Nov 2, 2026 | Insider trade | SEC |
| 8-K · Current report | Oct 28, 2026 | Management or board change | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Oct 28, 2026 | Results | SEC |
| 4 · Change in ownership | Aug 31, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 31, 2026 | Insider trade | SEC |
| 8-K · Current report | Aug 31, 2026 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 12, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 12, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 6, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jul 29, 2026 | Current report | SEC |
| 8-K · Current report | Jul 29, 2026 | Results | SEC |
| 8-K · Current report | Jul 8, 2026 | Management or board change | SEC |
| 8-K · Current report | Jun 18, 2026 | Management or board change | SEC |
| SD · Specialized disclosure | May 29, 2026 | ESG report | SEC |
| 4 · Change in ownership | May 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2026 | Insider trade | SEC |
| 8-K · Current report | May 20, 2026 | Meeting outcome | SEC |
| SCHEDULE 13G · Big-stake notice | May 14, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 14, 2026 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | May 11, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 6, 2026 | Quarterly report | SEC |
| 8-K · Current report | Apr 30, 2026 | Current report | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 29, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Apr 29, 2026 | Results | SEC |
| DEFA14A · Additional proxy material | Apr 17, 2026 | Meeting notice | SEC |
| 3 · Initial statement of ownership | Apr 14, 2026 | Insider trade | SEC |
| ARS · Annual report to shareholders | Apr 7, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 7, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 7, 2026 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Mar 27, 2026 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 26, 2026 | Big-stake notice | SEC |
| 10-K · Annual report | Feb 27, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 26, 2026 | Current report | SEC |
| 4 · Change in ownership | Feb 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 13, 2026 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Feb 12, 2026 | Other filings | SEC |
| 8-K · Current report | Feb 4, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jan 21, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | Oct 29, 2025 | Results | SEC |
| 8-K · Current report | Sep 18, 2025 | Management or board change | SEC |
| S-8 · Registration statement for employee plans | Aug 6, 2025 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 4, 2025 | Current report | SEC |
| 4 · Change in ownership | Aug 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 1, 2025 | Insider trade | SEC |
| 8-K · Current report | Jul 30, 2025 | Results | SEC |
| 4 · Change in ownership | Jul 7, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 7, 2025 | Insider trade | SEC |
| 8-K · Current report | Jul 2, 2025 | Management or board change | SEC |
| SD · Specialized disclosure | May 30, 2025 | ESG report | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 8-K · Current report | May 21, 2025 | Management or board change | SEC |
| 10-Q · Quarterly report | May 8, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 6, 2025 | Current report | SEC |
| 8-K · Current report | Apr 30, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 17, 2025 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Apr 8, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 8, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 8, 2025 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Mar 27, 2025 | Meeting notice | SEC |
| 10-K · Annual report | Feb 28, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 24, 2025 | Current report | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 8-K · Current report | Feb 5, 2025 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Jan 27, 2025 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Nov 25, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 5, 2024 | Quarterly report | SEC |
| 8-K · Current report | Oct 24, 2024 | Current report | SEC |
| 8-K · Current report | Oct 23, 2024 | Results | SEC |
| 4 · Change in ownership | Aug 19, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 2, 2024 | Quarterly report | SEC |
| 8-K · Current report | Jul 24, 2024 | Results | SEC |
| SD · Specialized disclosure | May 30, 2024 | ESG report | SEC |
| 4 · Change in ownership | May 24, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 24, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 24, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 24, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 24, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 24, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 24, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 24, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 24, 2024 | Insider trade | SEC |
| 8-K · Current report | May 22, 2024 | Management or board change | SEC |
| 4 · Change in ownership | May 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | May 3, 2024 | Quarterly report | SEC |
| 8-K · Current report | Apr 25, 2024 | Current report | SEC |
| 8-K · Current report | Apr 24, 2024 | Results | SEC |
| DEFR14A | Apr 16, 2024 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Apr 9, 2024 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 9, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 9, 2024 | Meeting notice | SEC |
| 4/A · Change in ownership, amended | Apr 5, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Apr 5, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Apr 5, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Apr 5, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Apr 5, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Mar 7, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 29, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 29, 2024 | Other filings | SEC |
| 10-K · Annual report | Feb 28, 2024 | Annual report | SEC |
| 144 · Notice of proposed sale | Feb 27, 2024 | Other filings | SEC |
| 4 · Change in ownership | Feb 22, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 22, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 22, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 22, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 22, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 9, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 9, 2024 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Feb 7, 2024 | Other filings | SEC |
| 8-K · Current report | Jan 31, 2024 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 24, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Jan 16, 2024 | Current report | SEC |
| 4 · Change in ownership | Dec 7, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 7, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 7, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 7, 2023 | Insider trade | SEC |
| 8-K · Current report | Dec 5, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Nov 9, 2023 | Insider trade | SEC |
| 8-K · Current report | Nov 3, 2023 | Current report | SEC |
| 10-Q · Quarterly report | Nov 3, 2023 | Quarterly report | SEC |
| 4 · Change in ownership | Nov 1, 2023 | Insider trade | SEC |
| 8-K · Current report | Oct 26, 2023 | Material contract | SEC |
| 8-K · Current report | Oct 25, 2023 | Results | SEC |
| 8-K · Current report | Sep 6, 2023 | Material contract | SEC |
| 8-K · Current report | Aug 23, 2023 | Current report | SEC |
| S-8 · Registration statement for employee plans | Aug 4, 2023 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 4, 2023 | Quarterly report | SEC |
| 8-K · Current report | Jul 26, 2023 | Results | SEC |
| 4 · Change in ownership | Jul 24, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 31, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 31, 2023 | Insider trade | SEC |
| SD · Specialized disclosure | May 31, 2023 | ESG report | SEC |
| 4 · Change in ownership | May 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2023 | Insider trade | SEC |
| 8-K · Current report | May 18, 2023 | Management or board change | SEC |
| 10-Q · Quarterly report | May 5, 2023 | Quarterly report | SEC |
| DEFA14A · Additional proxy material | May 1, 2023 | Meeting notice | SEC |
| 8-K · Current report | Apr 26, 2023 | Results | SEC |
| ARS · Annual report to shareholders | Apr 5, 2023 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 5, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 5, 2023 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Mar 23, 2023 | Meeting notice | SEC |
| 8-K · Current report | Mar 1, 2023 | Current report | SEC |
| 10-K · Annual report | Feb 27, 2023 | Annual report | SEC |
| 4 · Change in ownership | Feb 23, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2023 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2023 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 9, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 9, 2023 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 9, 2023 | Big-stake notice | SEC |
This page holds 200 of 1,001 filings. Open Filings
Cap table
Built by 6ix from Align Technology, Inc.’s releases
- Common shares
- 71,039,852
- Fully diluted
- 71,039,852
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 71,039,852 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 71,039,852 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Kevin T Conroy Other companies: Abbott Laboratories (Director · Since at least Apr 24, 2026); American Exceptionalism Acquisition Corp. A (Director · Since at least Sep 25, 2025); EXACT Sciences Corporation (President and CEO, Director · Since at least Mar 18, 2009); Adaptive Biotechnologies Corporation (Director · Jun 26, 2019 – Mar 6, 2023 · Past); ARYA Sciences Acquisition Corp (Director · Oct 5, 2018 – Jul 1, 2020 · Past); Epizyme Inc (Director · Feb 6, 2017 – Aug 12, 2022 · Past) | Director · Since at least Dec 5, 2023 |
| Quentin Blackford Other companies: iRhythm Holdings, Inc. (President, Chief Executive Officer and Director · Since at least Oct 4, 2021); Alphatec Holdings, Inc. (Director · Since at least Oct 2, 2017); Paragon 28 Inc (Director · Aug 1, 2022 – Apr 21, 2025 · Past); Axogen, Inc. (Director · Apr 26, 2019 – Mar 30, 2022 · Past); DexCom, Inc. (Chief Operating Officer · Sep 7, 2017 – Sep 8, 2021 · Past); NuVasive Inc (CFO · Jul 1, 2016 – Feb 8, 2017 · Past) | Director · Since at least Aug 27, 2026 |
| Britt Vitalone Other companies: Cheniere Energy Partners, LP (Director · Since at least Nov 5, 2026); Cheniere Energy, Inc. (Director · Since at least Jul 14, 2026); McKesson Corporation (EVP & CFO · Since at least Jan 1, 2018); Change Healthcare Inc (Director · Jun 27, 2019 – Jun 27, 2019 · Past) | Director · Since at least Jul 2, 2025 |
| Susan E Siegel Other companies: Illumina, Inc. (Director · Since at least Feb 5, 2019); Nevro Corp (Director · Dec 2, 2020 – Apr 3, 2025 · Past); Pacific Biosciences of California, Inc. (Director · Oct 26, 2010 – Jun 13, 2012 · Past); Affymetrix Inc (President, Director · Jan 3, 2006 – Jan 3, 2006 · Past) | Director · Since at least Mar 14, 2017 |
| Andrea Lynn Saia Other companies: Outset Medical, Inc. (Director · Since at least Mar 23, 2021); LivaNova PLC (Director · Jul 27, 2016 – Dec 31, 2023 · Past); Coca-Cola Enterprises Inc (Director · Jun 7, 2012 – Mar 31, 2016 · Past) | Director · Since at least Jul 25, 2013 |
| C Raymond Larkin Jr Other companies: Shockwave Medical Inc (Director · Mar 6, 2019 – May 31, 2024 · Past); HeartWare International Inc (Director · Oct 3, 2008 – Aug 23, 2016 · Past); DaVita Inc. (Director · Dec 31, 2005 – Mar 31, 2007 · Past) | Director · Since at least Feb 24, 2006 |
| David C Nagel Other companies: Vonage Holdings Corp (Director · Jul 30, 2010 – Apr 1, 2016 · Past); LeapFrog Enterprises Inc (Director · Jul 3, 2006 – May 31, 2012 · Past); Tessera Technologies Inc (Director · May 18, 2006 – Mar 30, 2012 · Past) | Director · Jul 15, 2009 – May 13, 2016 · Past |
| Joseph Lacob Other companies: NeuroPace, Inc. (Director · Since at least Apr 20, 2021); Orexigen Therapeutics Inc (Director · Apr 25, 2007 – May 27, 2011 · Past); eHealth, Inc. (Director · Oct 12, 2006 – Nov 8, 2007 · Past) | Director · Since at least May 24, 2006 |
| H Kent Bowen Other companies: CPS Technologies Corp. (Director · Dec 12, 2006 – Jun 13, 2008 · Past); ATI Inc. (Director · Jan 3, 2006 – May 9, 2008 · Past) | Director · May 24, 2006 – May 15, 2008 · Past |
| Sreelakshmi Kolli Other companies: Intuitive Surgical, Inc. (Executive Vice President, Chief Product and Digital Officer · Since at least Oct 27, 2023); Zimmer Biomet Holdings, Inc. (Director · Since at least Feb 18, 2021) | SVP & Mng Dir Info Tech · Nov 7, 2016 – Feb 20, 2020 · Past |
All 50 people
| Person | Seat |
|---|---|
| Dana Cambra Other companies: Pharsight Corp (SVP, R&D · May 5, 2008 – May 5, 2008 · Past) | VP, R&D · Jun 16, 2008 – Jun 18, 2012 · Past |
| George J. Morrow Other companies: Neurocrine Biosciences, Inc. (Director · Since at least May 18, 2022) | Director · Since at least May 18, 2022 |
| Greg J Santora Other companies: RetailMeNot Inc (Director · Apr 28, 2016 – May 23, 2017 · Past) | Director · Oct 27, 2015 – May 17, 2023 · Past |
| Jennifer Erfurth Other companies: Federal Signal Corporation (Vice President-Human Resources · Jul 12, 2010 – Jul 12, 2010 · Past) | VP, Global HR · Oct 1, 2012 – Feb 20, 2016 · Past |
| John Patrick Graham Other companies: Dutch Bros Inc. (Chief Marketing Officer · Sep 14, 2021 – Jan 3, 2023 · Past) | VP, Mktg & CMO · Jul 22, 2013 – May 5, 2015 · Past |
| Joseph M. Hogan Other companies: GE Aerospace (Senior Vice President · Feb 22, 2006 – May 1, 2008 · Past) | President and CEO, Director · Since at least Jun 1, 2015 |
| Julie Coletti Other companies: Illumina, Inc. (Chief Legal Officer · Since at least Jul 9, 2026) | EVP, CHIEF LEGAL & REGULATORY · Since at least Jul 20, 2022 |
| Kenneth Arola Other companies: Extreme Networks, Inc. (EVP Chief Financial Officer · Jun 2, 2014 – Jun 2, 2016 · Past) | VP, Finance and CFO · Dec 14, 2007 – Feb 20, 2013 · Past |
| Lynn Pendergrass Other companies: Sears Holdings Corp (President, Hardlines · Aug 17, 2015 – Aug 17, 2015 · Past) | VP, Americas · Feb 27, 2017 – Mar 20, 2017 · Past |
| Michael J Henry Other companies: Digital Realty Trust, Inc. (Chief Information Officer · May 11, 2015 – Feb 28, 2017 · Past) | VP, Info. Technology & CIO · Feb 1, 2007 – May 1, 2007 · Past |
| Mojdeh Poul Other companies: Integra LifeSciences Holdings Corporation (President & CEO, Director · Since at least Jan 6, 2026) | Director · Since at least May 21, 2025 |
| Raj Pudipeddi Other companies: Sonendo, Inc. (Director · Since at least Nov 5, 2026) | Senior Vice President and CMO · Since at least Nov 4, 2026 |
| Thomas M. Prescott Other companies: PROCEPT BioRobotics Corporation (CHAIRMAN OF THE BOARD · Since at least Jul 18, 2024) | Director · Feb 24, 2006 – May 19, 2021 · Past |
| Vamsi Mohan Raj Pudipeddi Other companies: Sonendo, Inc. (Director · Dec 6, 2021 – Sep 17, 2024 · Past) | SVP, Chief Marketing Officer · Feb 11, 2019 – May 18, 2020 · Past |
| Anne Myong | Director · Since at least May 17, 2024 |
| Dan Scott Ellis | Vp, No. American Sales · Nov 20, 2008 – Nov 16, 2012 · Past |
| Emory Wright | EVP, GLOBAL OPERATIONS · Nov 28, 2017 – Feb 20, 2024 · Past |
| Frank Quinn | Vice President and General Manager, United States · Since at least Oct 26, 2026 |
| Gil Laks | VP, International · Nov 20, 2008 – Feb 23, 2010 · Past |
| Hossein Arjomand | VP, Research & Development · Dec 1, 2005 – Nov 26, 2007 · Past |
| Jaime Holte Richardson | See Remarks · Since at least Apr 14, 2026 |
| Jennifer L. Davis | Company’s next President and Chief Executive Officer (from Dec 31, 2026) · Since at least Oct 28, 2026 |
| Jennifer Olson | SVP & Mng Dir Cust Service · May 16, 2019 – Nov 6, 2020 · Past |
| Jitse Marree | See Remarks · Since at least May 1, 2026 |
| John Morici | EVP, CHIEF FINANCIAL OFFICER · Since at least Feb 8, 2023 |
| Julie Colletti | SVP Chief Legal and Regulatory Officer · Since at least Nov 4, 2026 |
| Julie Tay | SVP & Mng Dir. Asia Pacific · Jul 22, 2015 – Dec 15, 2020 · Past |
| Kevin J Dallas | Director · Since at least Mar 1, 2018 |
| Len Hedge | SVP, Business Operations · Feb 24, 2006 – Feb 20, 2013 · Past |
| Markus Sebastian | SVP of the EMEA Region · Since at least Nov 4, 2026 |
| Raphael Pascaud | CMO & Bus. Dev. · Jan 13, 2014 – Oct 1, 2019 · Past |
| Richard M L Twomey | VP International · Jul 12, 2010 – Oct 30, 2013 · Past |
| Roger E. George | Senior Vice President, Chief Legal and Regulatory Officer · Since at least Feb 24, 2006 |
| Sheila K Tan | VP Marketing & CMO · Mar 3, 2009 – Nov 17, 2011 · Past |
| Simon Beard | SVP of the Americas Region · Since at least Dec 20, 2017 |
| Stuart A Hockridge | EVP, GLOBAL HR · Since at least May 23, 2016 |
| Timothy A Mack | VP, Bus Dev · Feb 20, 2012 – Feb 20, 2016 · Past |
| Warren S Thaler | Director · May 24, 2006 – May 17, 2023 · Past |
| Yuval Shaked | SVP & Mng Dir. Itero · Aug 8, 2018 – Nov 4, 2020 · Past |
| Zelko Relic | SVp, R&D and CTO · Aug 15, 2016 – Nov 4, 2020 · Past |
Log in to ask 6ix AI your own questions about Align Technology, Inc.